XENE Q1 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+101.1% YoY

Gross Profit

-$11M-120.9% margin

Operating Income

-$17M-198.1% margin

Net Income

-$20M-224.4% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+134.6%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$558M

Total Liabilities

$16M

Stockholders' Equity

$542M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$4M	+101.1%
Gross Profit	-$11M	-$12M	+11.3%
Operating Income	-$17M	-$16M	-8.2%
Net Income	-$20M	-$16M	-24.8%

Revenue Segments

License And Service

$9M100%